Skip to Content

Asparaginase Erwinia Chrysanthemi

In the US, Asparaginase Erwinia Chrysanthemi (asparaginase erwinia chrysanthemi systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphoblastic Leukemia and Acute Lymphocytic Leukemia.

US matches:

Ingredient matches for Asparaginase Erwinia Chrysanthemi


Asparaginase Erwinia Chrysanthemi (USAN) is known as Asparaginase in the US.


USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.